Immunoglobulin expression and its biological significance in cancer cells

Cellular and Molecular Immunology

Volumn 5, Issue 5, 2008, Pages 319-324

  Hu, Duosha ^a   Zheng, Hui ^a   Liu, Haidan ^a   Li, Ming ^a   Ren, Wei ^a   Liao, Wei ^a   Duan, Zhi ^a   Li, Lili ^a   Cao, Ya ^a  

^a Central South University   (China)

Author keywords

carcinoma; class switch; immunoglobulin; recombination; signal transduction

Indexed keywords

IMMUNOGLOBULIN;

B LYMPHOCYTE; BIOSYNTHESIS; CELL LINEAGE; COMPLEMENTARITY DETERMINING REGION; GENE REARRANGEMENT; HUMAN; IMMUNOLOGY; METABOLISM; NEOPLASM; REVIEW; VDJ EXON;

B-LYMPHOCYTES; CELL LINEAGE; COMPLEMENTARITY DETERMINING REGIONS; HUMANS; IMMUNOGLOBULIN CLASS SWITCHING; IMMUNOGLOBULINS; NEOPLASMS; VDJ EXONS;

EID: 65849256877     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2008.39     Document Type: Review

References (52)

1. Cao Y, Sun Y, Poirier S, et al. Isolation and partial characterization of a transformation-associated sequence from human nasopharyngeal carcinoma. Mol Carcinog. 1991;4:297-307.
2. Huber R. Spatial structure of imm (Pubitemid 11240879)
3. Virella G, Wang AC. Immunoglobulin structure. Immunol Ser. 1993;58:75-90.
4. Bassing CH, Swat W, Alt FW. The mechanism and regulation of chromosomal V (D) J recombination. Cell. 2002;109 Suppl: S45-55.
5. Dudley DD, Chaudhuri J, Bassing CH, Alt FW. Mechanism and control of V (D) J recombination versus class switch recombination: similarities and differences. Adv Immunol. 2005;86:43-112. (Pubitemid 40215690)
6. Eckhardt LA. Immunoglobulin gene expression only in the right cells at the right time. FASEB J. 1992;6:2553-2560.
7. Okazaki IM, Hiai H, Kakazu N, et al. Constitutive expression of AID leads to tumorigenesis. J Exp Med. 2003;197:1173-1181. (Pubitemid 36570072)
8. Okazaki IM, Kotani A, Honjo T. Role of AID in tumorigenesis. Adv Immunol. 2007;94:245-273. (Pubitemid 46856613)
9. Gonzalez D, van der Burg M, Garcia-Sanz R, et al. Immunoglobulin gene rearrangements and the pathogenesis of multiple myeloma. Blood. 2007;110:3112-3121. (Pubitemid 350106301)
10. Edry E, Melamed D. Class switch recombination: a friend and a foe. Clin Immunol. 2007;123:244-251. (Pubitemid 46818124)
11. Lefranc G, Lefranc MP. Regulation of the immunoglobulin gene transcription. Biochimie. 1990;72:7-17. (Pubitemid 20100863)
12. Li M, Tang M, Deng X. Positive immunoglobulin A expression in human epithelial carcinoma cell lines. Zhonghua Zhong Liu Za Zhi. 2001;23:451-453.
13. Kimoto Y. Expression of heavy-chain constant region of immunoglobulin and T-cell receptor gene transcripts in human non-hematopoietic tumor cell lines. Genes Chromosomes Cancer. 1998;22:83-86. (Pubitemid 28217811)
14. Li J, Tan C, Xiang Q, et al. Proteomic detection of changes in protein synthesis induced by NGX6 transfected in human nasopharyngeal carcinoma cells. J Protein Chem. 2001;20:265-271.
15. Okabe H, Satoh S, Kato T, et al. Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression. Cancer Res. 2001;61:2129-2137. (Pubitemid 32692038)
16. Zheng S, Cao J, Geng L. Structure and expression of colorectal cancer related immunoglobulin novel gene SNC73. Zhonghua Yi Xue Za Zhi. 2001;81:485-488.
17. Hu JB, Zheng S, Deng YC. Expression of a novel immunoglobulin gene SNC73 in human cancer and non-cancerous tissues. World J Gastroenterol. 2003;9:1054-1057. (Pubitemid 36681677)
18. Qiu X, Zhu X, Zhang L, et al. Human epithelial cancers secrete immunoglobulin G with unidentified specificity to promote growth and survival of tumor cells. Cancer Res. 2003;63:6488-6495. (Pubitemid 37255201)
19. Chen Z, Gu J. Immunoglobulin G expression in carcinomas and cancer cell lines. FASEB J. 2007;21:2931-2938. (Pubitemid 47372759)
20. Geng LY, Shi ZZ, Dong Q, et al. Expression of SNC73, a transcript of the immunoglobulin α-1 gene, in human epithelial carcinomas. World J Gastroenterol. 2007;13:2305-2311. (Pubitemid 46860730)
21. Zhu X, Li C, Sun X, et al. Immunoglobulin mRNA and protein expression in human oral epithelial tumor cells. Appl Immunohistochem Mol Morphol. 2008;16:232-238. (Pubitemid 351589554)
22. Huang J, Sun X, Mao Y, et al. Expression of immunoglobulin gene with classical V-(D)-J rearrangement in mouse brain neurons. Int J Biochem Cell Biol. 2008;40:1604-1615.
23. Zheng H, Li M, Ren W, et al. Expression and secretion of immunoglobulin α heavy chain with diverse VDJ recombinations by human epithelial cancer cells. Mol Immunol. 2007;44:2221-2227. (Pubitemid 46097112)
24. Xiao T, Ying W, Li L, et al. An approach to studying lung cancer-related proteins in human blood. Mol Cell Proteomics. 2005;4:1480-1486. (Pubitemid 41555474)
25. Ouyang G, Chen Y, Ruan L, et al. Differential phosphoproteome analysis of nasopharyngeal carcinoma and normal nasopharyngeal epithelial tissues. Int J Path Clin Med. 2007;27:461-469.
26. Nie G, Li M, Zhang P, et al. Differential proteomic analysis of sera from lung squamous carcinoma patients and healthy subjects. Int J Path Clin Med. 2007;27:470-475.
27. Goebel P, Janney N, Valenzuela JR, Romanow WJ, Murre C, Feeney AJ. Localized gene-specific induction of accessibility to V (D) J recombination induced by E2A and early B cell factor in nonlymphoid cells. J Exp Med. 2001;194:645-656. (Pubitemid 32844774)
28. Casali P, Schettino EW. Structure and function of natural antibodies. Curr Top Microbiol Immunol. 1996;210:167-179. (Pubitemid 26024271)
29. VanDyk L, Meek K. Assembly of IgH CDR3: mechanism, regulation, and influence on antibody diversity. Int Rev Immunol. 1992;8:123-133.
30. Babbage G, Ottensmeier CH, Blaydes J, Stevenson FK, Sahota SS. Immunoglobulin heavy chain locus events and expression of activation-induced cytidine deaminase in epithelial breast cancer cell lines. Cancer Res. 2006;66:3996-4000.
31. Zheng H, Li M, Liu H, et al. Immunoglobulin α heavy chain derived from human epithelial cancer cells promotes the access of S phase and growth of cancer cells. Cell Biol Int. 2007;31:82-87. (Pubitemid 46138048)
32. Iannello A, Ahmad A. Role of antibody-dependent cell-mediated cytotoxicity in the efficacy of therapeutic anti-cancer monoclonal antibodies. Cancer Metastasis Rev. 2005;24:487-499. (Pubitemid 43096997)
33. Weiner GJ. Monoclonal antibody mechanisms of action in cancer. Immunol Res. 2007;39:271-278. (Pubitemid 47574893)
34. Li M, Feng DY, Ren W, et al. Expression of immunoglobulin kappa light chain constant region in abnormal human cervical epithelial cells. Int J Biochem Cell Biol. 2004;36:2250-2257. (Pubitemid 39094446)
35. Ren W, Zheng H, Li M, et al. A functional single nucleotide polymorphism site detected in nasopharyngeal carcinomaassociated transforming gene Tx. Cancer Genet Cytogenet. 2005;157:49-52. (Pubitemid 40164858)
36. Vonderheide RH. Prospect of targeting the CD40 pathway for cancer therapy. Clin Cancer Res. 2007;13:1083-1088. (Pubitemid 46424046)
37. Xu Y, Song G. The role of CD40-CD154 interaction in cell immunoregulation. J Biomed Sci. 2004;11:426-438. (Pubitemid 38721026)
38. Pongubala JM, Atchison ML. Activating transcription factor 1 and cyclic AMP response element modulator can modulate the activity of the immunoglobulin kappa 3' enhancer. J Biol Chem. 1995;270:10304-10313.
39. Inlay MA, Gao HH, Odegard VH, Lin T, Schatz DG, Xu Y. Roles of the Igκ light chain intronic and 3' enhancers in Igκ somatic hypermutation. J Immunol. 2006;177:1146-1151. (Pubitemid 44036618)
40. Inlay MA, Lin T, Gao HH, Xu Y. Critical roles of the immunoglobulin intronic enhancers in maintaining the sequential rearrangement of IgH and Igκ loci. J Exp Med. 2006;203:1721-1732. (Pubitemid 44036278)
41. Schanke JT, Marcuzzi A, Podzorski RP, Van Ness B. An AP1 binding site upstream of the κ immunoglobulin intron enhancer binds inducible factors and contributes to expression. Nucleic Acids Res. 1994;22:5425-5432.
42. Schanke JT, Va n Ness B G. Organization of the transcription factor binding sites in the κ Ig intron enhancer. Effects of position, orientation, and spacing. J Immunol. 1994;153:4565-4572. (Pubitemid 24346851)
43. Izumi KM. Epstein-Barr virus signal transduction and B-lymphocyte growth transformation. Prog Mol Subcell Biol. 2004;36:269-288.
44. Lam N, Sugden B. CD40 and its viral mimic, LMP1: similar means to different ends. Cell Signal. 2003;15:9-16. (Pubitemid 35223624)
45. Zheng H, Li LL, Hu DS, Deng XY, Cao Y. Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma. Cell Mol Immunol. 2007;4:185-196.
46. Burgos JS. Involvement of the Epstein-Barr virus in the nasopharyngeal carcinoma pathogenesis. Med Oncol. 2005;22:113-121. (Pubitemid 41003443)
47. Eliopoulos A G, Young LS. LMP1 structure and signal transduction. Semin Cancer Biol. 2001;11:435-444. (Pubitemid 33105022)
48. Liao W, Tang M, Li JJ, Leo ML, Cao Y. Epstein-Barr virus encoded latent membrane protein 1 increases expression of immunoglobulin κ light chain through NFκB in a nasopharyngeal carcinoma cell line. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao. 1999;31:659-663.
49. Liu HD, Zheng H, Li M, Hu DS, Tang M, Cao Y. Upregulated expression of κ light chain by Epstein-Barr virus encoded latent membrane protein 1 in nasopharyngeal carcinoma cells via NF-κB and AP-1 pathways. Cell Signal. 2007;19:419-427. (Pubitemid 46001832)
50. Chan CF, Yau TO, Jin DY, Wong CM, Fan ST, Ng IO. Evaluation of nuclear factor-κB, urokinase-type plasminogen activator, and HBx and their clinicopathological significance in hepatocellular carcinoma. Clin Cancer Res. 2004;10:4140-4149. (Pubitemid 38812494)
51. Chung TW, Lee YC, Kim CH. Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERK and PI-3K/AKT pathways: involvement of invasive potential. FASEB J. 2004;18:1123-1125.
52. Tommasino M, Crawford L. Human papillomavirus E6 and E7: proteins which deregulate the cell cycle. Bioessays. 1995;17:509-518.